KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Asset Utilization Ratio (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 15 years of Asset Utilization Ratio data on record, last reported at 0.74 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 16.35% year-over-year to 0.74; the TTM value through Dec 2025 reached 0.74, down 16.35%, while the annual FY2025 figure was 0.78, 21.27% down from the prior year.
  • Asset Utilization Ratio reached 0.74 in Q4 2025 per ACAD's latest filing, down from 0.82 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.05 in Q4 2023 and bottomed at 0.6 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.84, with a median of 0.85 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 32.27% in 2022, then dropped 16.64% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.68 in 2021, then increased by 27.25% to 0.87 in 2022, then grew by 21.01% to 1.05 in 2023, then dropped by 15.85% to 0.88 in 2024, then fell by 16.35% to 0.74 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.74 in Q4 2025, 0.82 in Q3 2025, and 0.86 in Q2 2025.